- Home
- LARK vs ATOS Comparison
LARK vs ATOS Comparison
Compare LARK & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LARK
- ATOS
- Stock Information
- Founded
- LARK 1885
- ATOS 2009
- Country
- LARK United States
- ATOS United States
- Employees
- LARK N/A
- ATOS N/A
- Industry
- LARK Major Banks
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- LARK Finance
- ATOS Health Care
- Exchange
- LARK Nasdaq
- ATOS Nasdaq
- Market Cap
- LARK 136.3M
- ATOS 114.5M
- IPO Year
- LARK N/A
- ATOS 2012
- Fundamental
- Price
- LARK $24.11
- ATOS $0.80
- Analyst Decision
- LARK
- ATOS Strong Buy
- Analyst Count
- LARK 0
- ATOS 3
- Target Price
- LARK N/A
- ATOS $7.00
- AVG Volume (30 Days)
- LARK 9.3K
- ATOS 667.7K
- Earning Date
- LARK 02-04-2025
- ATOS 03-31-2025
- Dividend Yield
- LARK 3.44%
- ATOS N/A
- EPS Growth
- LARK 6.33
- ATOS N/A
- EPS
- LARK 2.26
- ATOS N/A
- Revenue
- LARK $58,168,000.00
- ATOS N/A
- Revenue This Year
- LARK N/A
- ATOS N/A
- Revenue Next Year
- LARK N/A
- ATOS N/A
- P/E Ratio
- LARK $11.22
- ATOS N/A
- Revenue Growth
- LARK 3.55
- ATOS N/A
- 52 Week Low
- LARK $17.05
- ATOS $0.72
- 52 Week High
- LARK $26.75
- ATOS $2.31
- Technical
- Relative Strength Index (RSI)
- LARK 46.44
- ATOS 41.00
- Support Level
- LARK $24.95
- ATOS $0.79
- Resistance Level
- LARK $26.13
- ATOS $0.89
- Average True Range (ATR)
- LARK 1.02
- ATOS 0.05
- MACD
- LARK -0.02
- ATOS 0.01
- Stochastic Oscillator
- LARK 30.89
- ATOS 25.14
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.